Long-Term Assets: The sum of all assets classified as non-current.
Gilead Sciences, Inc. (GILD) had Long-Term Assets of $35.42B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$7.80B |
|
$-10.50B |
|
$1.58B |
|
$6.22B |
|
$18.20B |
|
$-10.39B |
|
$140.00M |
|
$-10.25B |
|
$-10.25B |
|
$-10.50B |
|
$-10.50B |
|
$-10.50B |
|
$-10.50B |
|
$-10.39B |
|
$-9.70B |
|
1.24B |
|
1.24B |
|
$-8.45 |
|
$-8.45 |
|
| Balance Sheet Financials | |
$13.95B |
|
$5.83B |
|
|
Long-Term Assets |
$35.42B |
$49.36B |
|
$11.02B |
|
$23.83B |
|
$26.60B |
|
$37.62B |
|
$11.74B |
|
$-10.60B |
|
$11.74B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$6.12B |
|
$-8.58B |
|
$-1.90B |
|
$7.56B |
|
$3.18B |
|
$-4.38B |
|
$449.00M |
|
$-2.07B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
0.67 |
|
2.23 |
|
79.76% |
|
-133.21% |
|
-133.21% |
|
-- |
|
-131.41% |
|
-134.51% |
|
$5.86B |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.81 |
|
1.54 |
|
58.30 |
|
-89.37% |
|
99.00% |
|
-21.26% |
|
-29.50% |
|
$9.46 |
|
$4.71 |
|
$4.92 |
|